The following report was received via e-mail:
During a routine inspection, three unreported [prostate brachytherapy] medical events were identified.
Case One:
Implant Date: 6/4/2009
Prescribed dose: 145Gy to the prostate
Post implant CT dosimetry: V100 (the volume of the prostate receiving 100% of the prescribed dose) totaled 69.71%
Source: I-125 encapsulated seeds
Vendor: IsoAid
Model Number: IAI-125A
Activity per seed: 0.330 mCi
Number of seeds implanted: 69
Case Two:
Implant Date: 6/19/2009
Prescribed dose: 145Gy to the prostate
Post implant CT dosimetry: V100 (the volume of the prostate receiving 100% of the prescribed dose) totaled 62.77%
Source: I-125 encapsulated seeds
Vendor: IsoAid
Model Number: IAI-125A
Activity per seed: 0.330 mCi
Number of seeds implanted: 80
Case Three:
Implant Date: 10/29/2009
Prescribed dose: 145Gy to the prostate
Post implant CT dosimetry: V100 (the volume of the prostate receiving 100% of the prescribed dose) totaled 65.34%
Source: I-125 encapsulated seeds
Vendor: IsoAid
Model Number: IAI-125A
Activity per seed: 0.330 mCi
Number of seeds implanted: 84
- * * UPDATE FROM CURT PENDERGRASS TO HOWIE CROUCH VIA EMAIL ON 6/5/12 AT 1018 EDT * * *
D90 is defined as minimum dose received by 90% of CT-defined prostate volume
Case 1 D90 = 72.80% of 145Gy
Case 2 D90 = 58.86% of 145Gy
Case 3 D90 = 54.00% of 145Gy
Notified R1DO (Cahill) and FSME Events via email.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.